Iron status during anti-TNF therapy in children with juvenile idiopathic arthritis

Clinical Rheumatology

Volumn 30, Issue 1, 2011, Pages 115-119

  Aalto, Kristiina ^a   Honkanen, Visa ^a   Lahdenne, Pekka ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Anaemia; Anti TNF therapy; Juvenile arthritis

Indexed keywords

DISEASE MODIFYING ANTIRHEUMATIC DRUG; ETANERCEPT; FERRITIN; HEMOGLOBIN; HYDROXYCHLOROQUINE; INFLIXIMAB; IRON; METHOTREXATE; PREDNISOLONE; TRANSFERRIN; TRANSFERRIN RECEPTOR;

ADOLESCENT; ANALYTICAL PARAMETERS; ARTHRITIS; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG DOSE REDUCTION; DRUG EFFECT; DRUG WITHDRAWAL; ERYTHROCYTE COUNT; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FERRITIN BLOOD LEVEL; FERRITIN INDEX; HUMAN; IRON BLOOD LEVEL; IRON DEFICIENCY; IRON DEFICIENCY ANEMIA; JUVENILE RHEUMATOID ARTHRITIS; LOW DRUG DOSE; MALE; MEAN CORPUSCULAR VOLUME; POLYARTHRITIS; PRESCHOOL CHILD; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; SCHOOL CHILD; TREATMENT DURATION;

ADOLESCENT; ANTIBODIES, MONOCLONAL; ARTHRITIS, JUVENILE RHEUMATOID; CHILD; CHILD, PRESCHOOL; FEMALE; HEMOGLOBINS; HUMANS; IMMUNOGLOBULIN G; IMMUNOLOGIC FACTORS; INFLAMMATION; IRON; MALE; RECEPTORS, TRANSFERRIN; RECEPTORS, TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79151475267     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-010-1571-7     Document Type: Article

References (21)

1. B Kirel S Yetgin U Saatci S Ozen A Bakkaloglu N Besbas 1996 Anaemia in juvenile chronic arthritis Clin Rheumatol 15 236 241 1:STN:280: DyaK28zosFeqtw%3D%3D 10.1007/BF02229700 8793253
2. HA Papadaki HD Kritikos V Valatas DT Boumpas GD Eliopoulos 2002 Anemia of chronic disease in rheumatoid arthritis is associated with increased apoptosis of bone marrow erythroid cells: improvement following anti-tumor necrosis factor-alpha antibody therapy Blood 100 474 482 1:CAS:528:DC%2BD38XlsVWgt74%3D 10.1182/blood-2002-01-0136 12091338
3. LS Rusten SE Jacobsen 1995 Tumor necrosis factor (TNF)-alpha directly inhibits human erythropoiesis in vitro: role of p55 and p75 TNF receptors Blood 85 989 996 1:CAS:528:DyaK2MXjs1OjtLY%3D 7849320
4. G Vreugdenhil B Lowenberg HG Van Eijk AJ Swaak 1992 Tumor necrosis factor alpha is associated with disease activity and the degree of anemia in patients with rheumatoid arthritis Eur J Clin Investig 22 488 493 1:STN:280: DyaK38zoslWqtg%3D%3D 10.1111/j.1365-2362.1992.tb01495.x
5. MB Atkins K Kappler JW Mier RE Isaacs EM Berkman 1995 Interleukin-6-associated anemia: determination of the underlying mechanism Blood 86 1288 1291 1:CAS:528:DyaK2MXnsVClsLs%3D 7632934
6. AR Harvey MJ Pippard BM Ansell 1987 Microcytic anaemia in juvenile chronic arthritis Scand J Rheumatol 16 53 59 1:STN:280:DyaL2s3jsVWluw%3D%3D 3589590
7. NJ Minaur RK Jacoby JA Cosh G Taylor JJ Rasker 2004 Outcome after 40 years with rheumatoid arthritis: a prospective study of function, disease activity, and mortality J Rheumatol Suppl 69 3 8 15053445
8. JD Cook 2005 Diagnosis and management of iron-deficiency anaemia Best Pract Res Clin Haematol 18 319 332 1:CAS:528:DC%2BD2MXhvVSmtbg%3D 10.1016/j.beha.2004.08.022 15737893
9. T Pettersson SM Kivivuori MA Siimes 1994 Is serum transferrin receptor useful for detecting iron-deficiency in anaemic patients with chronic inflammatory diseases? Br J Rheumatol 33 740 744 1:STN:280:DyaK2czjt1Cltg%3D%3D 10.1093/rheumatology/33.8.740 8055201
10. K Punnonen O Kaipiainen-Seppanen L Riittinen T Tuomisto T Hongisto L Penttila 2000 Evaluation of iron status in anemic patients with rheumatoid arthritis using an automated immunoturbidimetric assay for transferrin receptor Clin Chem Lab Med 38 1297 1300 1:CAS:528:DC%2BD3MXhsFWhu78%3D 10.1515/CCLM.2000.205 11205697
11. MB Zimmermann 2008 Methods to assess iron and iodine status Br J Nutr 99 S2 S9 1:CAS:528:DC%2BD1cXptlaktrY%3D 10.1017/S000711450800679X 18598585
12. BS Skikne 2008 Serum transferrin receptor Am J Hematol 83 872 875 1:CAS:528:DC%2BD1cXhsVyntLnJ 10.1002/ajh.21279 18821709
13. M Angeles Vázquez López FL Molinos ML Carmona AC Morales FJ Muñoz Vico JL Muñoz A Muñoz Hoyos 2006 Serum transferrin receptor in children: usefulness for determinating the nature of anemia in infection J Pediatr Hematol Oncol 28 809 815 10.1097/MPH.0b013e31802d751a 17164650
14. P Lahdenne P Vahasalo V Honkanen 2003 Infliximab or etanercept in the treatment of children with refractory juvenile idiopathic arthritis: an open label study Ann Rheum Dis 62 245 247 1:CAS:528:DC%2BD3sXisVGmurk%3D 10.1136/ard.62.3.245 12594111
15. RE Petty TR Southwood P Manners J Baum DN Glass J Goldenberg, et al. 2004 International League of Associations for Rheumatology. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001 J Rheumatol 31 390 392 14760812
16. EH Giannini N Ruperto A Ravelli DJ Lovell DT Felson A Martini 1997 Preliminary definition of improvement in juvenile arthritis Arthritis Rheum 40 1202 1209 1:STN:280:DyaK2szlslSlug%3D%3D 9214419
17. RF Labbé A Dewanji 2004 Iron assessment tests: transferrin receptor vis-à-vis zinc protoporphyrin Clin Biochem 37 165 174 10.1016/j.clinbiochem.2003.10.006 14972637
18. R Crowell AM Ferris RJ Wood P Joyce H Slivka 2006 Comparative effectiveness of zinc protoporphyrin and hemoglobin concentrations in identifying iron deficiency in a group of low-income, preschool-aged children: practical implications of recent illness Pediatrics 118 224 232 10.1542/peds.2006-0156 16818569
19. P Suominen K Punnonen A Rajamaki K Irjala 1998 Serum transferrin receptor and transferrin receptor-ferritin index identify healthy subjects with subclinical iron deficits Blood 92 2934 2939 1:CAS:528:DyaK1cXms1elur4%3D 9763580
20. S Puntarulo 2005 Iron, oxidative stress and human health Mol Aspects Med 26 299 312 1:CAS:528:DC%2BD2MXpslygtbg%3D 10.1016/j.mam.2005.07.001 16102805
21. G Weiss 2002 Pathogenesis and treatment of anaemia of chronic disease Blood Rev 16 87 96 10.1054/blre.2002.0193 12127952